BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26238486)

  • 21. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
    Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
    Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.
    Yurchenko E; Shio MT; Huang TC; Da Silva Martins M; Szyf M; Levings MK; Olivier M; Piccirillo CA
    PLoS One; 2012; 7(4):e35572. PubMed ID: 22545118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function.
    Zhang L; Tschumi BO; Corgnac S; Rüegg MA; Hall MN; Mach JP; Romero P; Donda A
    J Immunol; 2014 Aug; 193(4):1759-65. PubMed ID: 25015820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opposing Roles of DCs and iNKT Cells in the Induction of Foxp3 Expression by MLN CD25
    Lee SW; Park HJ; Van Kaer L; Hong S
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
    Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
    Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity.
    de Araújo FF; Corrêa-Oliveira R; Rocha MO; Chaves AT; Fiuza JA; Fares RC; Ferreira KS; Nunes MC; Keesen TS; Damasio MP; Teixeira-Carvalho A; Gomes JA
    Immunobiology; 2012 Aug; 217(8):768-77. PubMed ID: 22672991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
    Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
    Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogen-expanded CD11b+ invariant NKT cells feedback inhibit T cell proliferation via membrane-bound TGF-β1.
    Han Y; Jiang Z; Chen Z; Gu Y; Liu Y; Zhang X; Cao X
    J Autoimmun; 2015 Apr; 58():21-35. PubMed ID: 25592391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mTOR and its tight regulation for iNKT cell development and effector function.
    Yang W; Gorentla B; Zhong XP; Shin J
    Mol Immunol; 2015 Dec; 68(2 Pt C):536-45. PubMed ID: 26253278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity.
    Lynch L; O'Shea D; Winter DC; Geoghegan J; Doherty DG; O'Farrelly C
    Eur J Immunol; 2009 Jul; 39(7):1893-901. PubMed ID: 19585513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+CD25+Foxp3+IFN-γ+ human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically.
    Daniel V; Sadeghi M; Wang H; Opelz G
    Hum Immunol; 2011 Sep; 72(9):699-707. PubMed ID: 21664396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+CD25+ T regs with acetylated FoxP3 are associated with immune suppression in human leprosy.
    Kumar S; Naqvi RA; Ali R; Rani R; Khanna N; Rao DN
    Mol Immunol; 2013 Dec; 56(4):513-20. PubMed ID: 23911408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
    Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapamycin-sensitive signals control TCR/CD28-driven Ifng, Il4 and Foxp3 transcription and promoter region methylation.
    Tomasoni R; Basso V; Pilipow K; Sitia G; Saccani S; Agresti A; Mietton F; Natoli G; Colombetti S; Mondino A
    Eur J Immunol; 2011 Jul; 41(7):2086-96. PubMed ID: 21480212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction.
    Fedoric B; Krishnan R
    Immunol Lett; 2008 Oct; 120(1-2):49-56. PubMed ID: 18652845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
    Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M
    Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfatide inhibits α-galactosylceramide presentation by dendritic cells.
    Kanamori M; Tasumi Y; Iyoda T; Ushida M; Inaba K
    Int Immunol; 2012 Feb; 24(2):129-36. PubMed ID: 22247226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.